Meeting ReportOncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - GU

Phase 3 trial of [177Lu]Lu-PSMA-617 in taxane-naive patients with metastatic castration-resistant prostate cancer (PSMAfore)

Ken Herrmann, Oliver Sartor, Daniel Castellano, Johann de Bono, Neal Shore, Kim Chi, Mike Crosby, Josep Piulats, Aude Flechon, Xiao Wei, Hakim Mahammedi, Guilhem Roubaud, Hana Študentová, Samson Ghebremariam, Euloge Kpamegan, Teri Kreisl, Neda Delgoshaie, Katja Lehnhoff, Michael Morris and Karim Fizazi
Journal of Nuclear Medicine June 2024, 65 (supplement 2) 241064;

Article Information

vol. 65 no. supplement 2 241064
Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online June 9, 2024.
Copyright & Usage 
© 2024

Author Information

  1. Ken Herrmann1,
  2. Oliver Sartor2,
  3. Daniel Castellano3,
  4. Johann de Bono4,
  5. Neal Shore5,
  6. Kim Chi6,
  7. Mike Crosby7,
  8. Josep Piulats8,
  9. Aude Flechon9,
  10. Xiao Wei10,
  11. Hakim Mahammedi11,
  12. Guilhem Roubaud12,
  13. Hana Študentová13,
  14. Samson Ghebremariam14,
  15. Euloge Kpamegan14,
  16. Teri Kreisl14,
  17. Neda Delgoshaie15,
  18. Katja Lehnhoff15,
  19. Michael Morris16 and
  20. Karim Fizazi17
  1. 1Department of Nuclear Medicine, University Hospital Essen, Essen, Germany
  2. 2Mayo Clinic
  3. 3Hospital Universitario 12 de Octubre, Madrid, Spain
  4. 4The Institute of Cancer Research and The Royal Marsden Hospital, London, UK
  5. 5Carolina Urologic Research Center and GenesisCare US, Myrtle Beach, SC, USA
  6. 6BC Cancer
  7. 7Veterans Prostate Cancer Awareness
  8. 8Catalan Institute of Oncology, Barcelona, Spain
  9. 9Centre Léon Bérard, Lyon, France
  10. 10Dana-Farber Cancer Institute, Boston, MA, USA
  11. 11Centre Jean Perrin, Clermont-Ferrand, France
  12. 12Institut Bergonié, Bordeaux, France
  13. 13Palacký University, Faculty of Medicine and Dentistry and University Hospital, Olomouc, Czech Republic
  14. 14Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
  15. 15Novartis Pharma AG, Basel, Switzerland
  16. 16Memorial Sloan Kettering Cancer Center
  17. 17Gustave Roussy Institute, Paris-Saclay University, Villejuif, France

Statistics from Altmetric.com

Cited By...

Article usage

Article usage: June 2024 to March 2025

AbstractFullPdf
Jun 20248400
Jul 202422000
Aug 202419600
Sep 202421400
Oct 202413400
Nov 202413700
Dec 202411000
Jan 202516400
Feb 202515600
Mar 202516100
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 65, Issue supplement 2
June 1, 2024
Article Alerts
Email Article
Citation Tools
Bookmark this article

Jump to section